Αποτελέσματα Αναζήτησης
It is especially important to fully understand the safety and efficacy of dietary supplements and medical foods used in the care of mitochondrial patients to better inform decisions made by patients and clinicians about the best use of these management modalities.
- Mitochondrial myopathies diagnosed in adulthood: clinico-genetic ...
We performed a retrospective chart review of adult patients...
- Mitochondrial myopathies diagnosed in adulthood: clinico-genetic ...
Certain dietary supplements may be of value in treating PMDs because, as nutrients and metabolic cofactors, they help increase mitochondrial ATP production, bypass a cellular defect (e.g., a deficiency in the activity of complexes I, II, or III in the ETC), or remove toxic metabolites [9, 14].
12 Ιουν 2024 · Depending on the specific type of mitochondrial disease, common symptoms include muscle weakness, imbalance, gastrointestinal problems, poor growth, liver disease, heart disease, diabetes, visual and hearing issues, lactic acidosis, and developmental delays. Mitochondrial disease may be inherited.
Diet: Dietary needs are extremely variable from patient to patient with mitochondrial myopathies. It is required to evaluate a patient’s nutritional deficiencies. Potential therapies include supplementing caloric intake, enteral feeding, increasing the frequency of meals, limited fasting, and parenteral nutrition ( Parikh et al., 2009 ).
Someone with Mitochondrial myopathy who is generally on a high protein, low sugar diet finds that when she needs an IV, switching to dextrose (sugar) and water rather than saline makes her feel better - why is this?
14 Φεβ 2024 · We performed a retrospective chart review of adult patients diagnosed with mitochondrial myopathy at Mayo Clinic (2005–21). We identified 94 patients. Median time from symptom onset to diagnosis was 11 years (interquartile range 4–21 years). Median age at diagnosis was 48 years (32–63 years).
The estimate of nutritional status, energy needs and nutritional behaviors are firstly discussed. Then, we go in-depth on the scientific rationale and the clinical evidence of the use of anti-oxidants and enzyme-cofactors in the clinical practice.
